(S)-Thalidomide
CAS No. 841-67-8
(S)-Thalidomide ( —— )
产品货号. M33094 CAS No. 841-67-8
(S)-Thalidomide ((S)-(-)-Thalidomide) 是 Thalidomide 的 S-对映体。(S)-Thalidomide 具有免疫调节,抗炎,抗血管生成和促凋亡作用。(S)-Thalidomide 通过与 cereblon (CRBN) 结合诱导致畸作用。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥550 | 有现货 |
|
| 10MG | ¥847 | 有现货 |
|
| 25MG | ¥1841 | 有现货 |
|
| 50MG | ¥2930 | 有现货 |
|
| 100MG | ¥4068 | 有现货 |
|
| 200MG | ¥5715 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称(S)-Thalidomide
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述(S)-Thalidomide ((S)-(-)-Thalidomide) 是 Thalidomide 的 S-对映体。(S)-Thalidomide 具有免疫调节,抗炎,抗血管生成和促凋亡作用。(S)-Thalidomide 通过与 cereblon (CRBN) 结合诱导致畸作用。
-
产品描述(S)-Thalidomide ((S)-(-)-Thalidomide) is the S-enantiomer of Thalidomide. (S)-Thalidomide has immunomodulatory, anti-inflammatory, antiangiogenic and pro-apoptotic effects. (S)-Thalidomide induces teratogenic effects by binding to cereblon (CRBN) .
-
体外实验(S)-Thalidomide treatment results in a reduction in cell viability in U266 cells with an IC50 of 362 μM.(S)-Thalidomide treatment increased apoptosis in a dose-dependent manner in U266 cells.There are changes in the expression profile of genes involved in angiogenesis and apoptosis, but the changes are most dramatic in the apoptotic genes. In particular, the expression of I-κB kinase is decreased by two-fold, which is associated with a four-fold decrease in NF-κB expression. (S)-Thalidomide increases the Bax:Bcl-2 ratio, alsoincreases I-kB protein levels, and decreases NF-kB activity. A dramatic decrease in Bcl-2 expression with (S)-Thalidomide suggests a possible enhancement of cytotoxic effect if combined with other cytotoxic agents.Cell Viability Assay Cell Line:U266 MM cells Concentration:0 μM, 10 μM, 100 μM, 150 μM, 200 μM, 1000 μM Incubation Time:3 days Result:A reduction in cell viability was observed in U266 cells.Apoptosis Analysis Cell Line:U266 MM cells Concentration:100 μM, 150 μM, 200 μM, 1000 μM Incubation Time:3 days Result:Increased apoptosis in U266 cells.
-
体内实验Thalidomide does cause limb reduction defects in chick embryos as long as the embryos are directly exposed to the drug. The most useful techniques are implanting Thalidomide-soaked beads into the embryo immediately adjacent to the limb territory or soaking presumptive chick limb territories in Thalidomide and then grafting the explants to a host embryo celom. Thalidomide affects the chick limb grafted to a host embryo in a dose response fashion. Furthermore, (S)-Thalidomide is more teratogenic than (R)-Thalidomide.
-
同义词——
-
通路Apoptosis
-
靶点Apoptosis
-
受体Apoptosis
-
研究领域——
-
适应症——
化学信息
-
CAS Number841-67-8
-
分子量258.23
-
分子式C13H10N2O4
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 83.33 mg/mL (322.70 mM; 超声助溶 )
-
SMILESO=C1N(C(=O)C=2C1=CC=CC2)[C@@H]3C(=O)NC(=O)CC3
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Liu WM, et al. s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line. Hematol J. 2004;5(3):247-54.?
产品手册
关联产品
-
PBOX 6
PBOX 6 是一种 pyrrolo-1,5-benzoxazepine (PBOX) 化合物,可作为微管解聚剂和促凋亡剂起作用。
-
Apoptosis Activator ...
一种细胞凋亡激活剂,可强烈诱导 caspase-3 激活、PARP 裂解和 DNA 片段化。
-
ZDLD20
ZDLD20 是一种 β-咔啉,是一种选择性、具有口服活性的 CDK4/CycD3 抑制剂,IC50 值为 6.51 μM。ZDLD20 表现出有效的抗 HCT116 活性,包括抑制集落形成、抑制侵袭和迁移、诱导细胞凋亡和阻止细胞周期的 G1 期。ZDLD20 表现出有效的抗癌活性。
021-51111890
购物车()
sales@molnova.cn

